DMBA
BIO icon

Deseret Mutual Benefit Administrators’s Bio-Rad Laboratories Class A BIO Stock Holding History

Deseret Mutual Benefit Administrators’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10
Closed -$2.8K – 503
2025
Q3 		$2.8K Hold
10
– – ﹤0.01% 505
2025
Q2 		$2.41K Hold
10
– – ﹤0.01% 485
2025
Q1 		$2.44K Hold
10
– – ﹤0.01% 486
2024
Q4 		$3.29K Sell
10
-4
-29% -$1.36K ﹤0.01% 470
2024
Q3 		$4.68K Sell
14
-21
-60% -$6.67K ﹤0.01% 479
2024
Q2 		$9.56K Hold
35
– – ﹤0.01% 472
2024
Q1 		$12.1K Hold
35
– – 0.01% 459
2023
Q4 		$11.3K Buy
35
+20
+133% +$6.27K 0.01% 461
2023
Q3 		$5.38K Hold
15
– – ﹤0.01% 488
2023
Q2 		$5.69K Buy
+15
New +$6.1K ﹤0.01% 485

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return